NCT03180268
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Read More at ClinicalTrials.govInvestigators: Lia Halasz, MD
We have many clinical trials open that involve radiation therapy for cancer open for enrollment of patients. The trials for specific types of cancer are listed below.
About Clinical Trials
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are done to find out if new cancer treatments are effective, safe and better than the standard treatment. Many of today’s standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment. Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and improve the treatment of cancer.
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Read More at ClinicalTrials.govInvestigators: Lia Halasz, MD
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Read More at ClinicalTrials.govInvestigators: Lia Halasz, MD
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Read More at ClinicalTrials.govInvestigators: George Laramore, MD, PhD, FACR, FASTRO
Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
Read More at ClinicalTrials.govInvestigators: Christine Fang, MD
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Read More at ClinicalTrials.govInvestigators: Janice Kim, MD
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
Read More at ClinicalTrials.govInvestigators: Janice Kim, MD
Gemcitabine Hydrochloride and Cisplatin With or Without Radiation Therapy in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
Read More at ClinicalTrials.govInvestigators: Smith “Jim” Apisarnthanarax, MD
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD
TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
Read More at ClinicalTrials.govInvestigators: Nina Mayr, MD, FASTRO, FAAAS
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
Read More at ClinicalTrials.govInvestigators: Jing Zeng, MD
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Read More at ClinicalTrials.govInvestigators: Ramesh Rengan, MD, PhD, FASTRO
Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, and Nivolumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
Read More at ClinicalTrials.govInvestigators: Ramesh Rengan, MD, PhD, FASTRO
Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, and Nivolumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
Read More at ClinicalTrials.govInvestigators: Ramesh Rengan, MD, PhD, FASTRO